• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHB2500817 多替拉韦钠片 Tablet Chemical Drugs(4) Supplementary Application 2025-04-24 Jiangsu Hechen Pharmaceutical Co Ltd;Aurisco Pharmaceutical Co Ltd view
CYHS2200638 多替拉韦钠片 Tablet Chemical Drugs(4) Generic Drug 2022-04-24 QILU Pharmaceutical Co Ltd view
CYHS2401058 多替拉韦钠片 Tablet Chemical Drugs(4) Generic Drug 2024-04-10 Shanghai DESANO Biopharmaceutical Co Ltd view
CYHS2402993 多替拉韦钠片 Tablet Chemical Drugs(4) Generic Drug 2024-09-10 Yangzhou Aurisco Pharmaceutical Co Ltd;Jiangsu Hechen Pharmaceutical Co Ltd view
CYHS2404038 多替拉韦钠片 Tablet Chemical Drugs(4) Generic Drug 2024-11-23 Jiangsu Aidea Pharmaceutical Co Ltd view
CYHS2404620 多替拉韦钠片 Tablet Chemical Drugs(4) Generic Drug 2024-12-31 Shijiazhuang Lonzeal Pharmaceuticals Co Ltd view
CYHS2501437 多替拉韦钠片 Tablet Chemical Drugs(4) Generic Drug 2025-04-15 NORTHEAST Pharmaceutical Group Shenyang NO1 Pharmaceutical Co Ltd view
CYHS2501764 多替拉韦钠片 Tablet Chemical Drugs(4) Generic Drug 2025-05-15 Anhui Biochem Bio-Pharmaceutical Co Ltd view
JTH1800205 多替拉韦钠片 Tablet Chemical Drugs Disposable Import Drug Application 2018-06-20 Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) Glaxo Operations UK Ltd;GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare Uk Ltd Certificate Issued 2018-07-10 view
JTH1800206 多替拉韦钠片 Tablet Chemical Drugs Disposable Import Drug Application 2018-06-20 Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) Glaxo Operations UK Ltd;GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare Uk Ltd Certificate Issued 2018-07-10 view
JXHL1400107 多替拉韦钠片 Tablet Chemical Drugs Import Drug Application 2014-04-17 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare Uk Ltd Certificate Issued 2015-03-27 view
JXHL1400159 多替拉韦钠片 Tablet Chemical Drugs Import Drug Application 2014-05-22 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare Uk Ltd Certificate Issued 2015-03-04 view
JXHS1500037 多替拉韦钠片 Tablet Chemical Drugs Import Drug Application 2015-04-24 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Viiv Healthcare Uk Ltd Certificate Issued 2016-01-11 view
JYHB1600799 多替拉韦钠片 Tablet Chemical Drugs Supplementary Application 2016-06-22 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Viiv Healthcare Uk Ltd Certificate Issued 2017-01-04 view
JYHB1800246 多替拉韦钠片 Tablet Chemical Drugs Supplementary Application 2018-03-12 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Viiv Healthcare Uk Ltd Certificate Issued 2019-07-01 view
JYHB1800247 多替拉韦钠片 Tablet Chemical Drugs Supplementary Application 2018-03-12 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Viiv Healthcare Uk Ltd Certificate Issued 2019-07-01 view
JYHB2000101 多替拉韦钠片 Tablet Chemical Drugs Supplementary Application 2020-03-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd Certificate Issued 2020-06-19 view
JYHB2000102 多替拉韦钠片 Tablet Chemical Drugs Supplementary Application 2020-03-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd Certificate Issued 2020-06-19 view
JYHB2000262 多替拉韦钠片 Tablet Chemical Drugs Supplementary Application 2020-03-30 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd Certificate Issued 2020-04-24 view
JYHB2000691 多替拉韦钠片 Tablet Chemical Drugs Supplementary Application 2020-07-06 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;GlaxoSmithKline Phaemaceuticals SA Certificate Issued 2021-11-12 view